Valued at USD 24.78 billion in 2024, the global hepatic disease treatment market is expected to reach USD 45.22 billion by 2034, expanding at a CAGR of 6.20% during the forecast period. This growth is primarily driven by the increasing prevalence of liver-related disorders across the 8 major markets. Advancements in treatment options and rising awareness about liver health are also co... https://www.expertmarketresearch.com/reports/hepatic-disease-treatment-market